ReviewCureus2026
Analysis of the 2013-2020 WHO Global Action Plan for the Prevention and Control of Noncommunicable Diseases Using the 2008 Davies Provenance Framework.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Noncommunicable diseases (NCDs) account for 41 million deaths annually, making them the world's leading cause of death. To address this growing crisis, the World Health Organization (WHO) introduced and implemented the Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020. In this plan, the WHO provided a strategic roadmap to achieve a relative reduction of 25% in premature NCD deaths by 2025. By utilizing and adapting the 2008 Davies Provenance Framework, this review critically evaluated the WHO Global Action Plan. This framework, a policy analysis tool, was adopted to systematically assess the action plan's origins, priorities, stakeholder involvement, implementation procedures, and potential perversities. The action plan successfully called for multisectoral collaboration, from the national to the global level, and empowered WHO Member States to adapt its implementation to their unique national circumstances. This analysis revealed anticipated structural resistance arising from competing national development priorities and private-sector interests, particularly those of the alcohol and tobacco industries. The WHO Global Action Plan offers an extensive and well-structured basis for reducing the global burden of NCDs. However, its success depends on its joint adoption by all stakeholders and on having transformational and transactional leaders champion the drive for behavioral change while addressing unintended perversities.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.